Twitter | Search | |
Search Refresh
Edesa Biotech Inc. Sep 5
grants approval to begin a clinical study for new treatment in an indication where there has been little to no innovation in many years, despite the high prevalence. Up to 48 patients to be enrolled.
Reply Retweet Like
Quanticate 8h
[Free Whitepaper] Flexible Phase I Study Designs: Expediting Early Clinical Drug Development
Reply Retweet Like
VladK Aug 29
Reply Retweet Like
Pharma Recruitment Aug 6
. has announced that its migraine prevention drug Emgality (galcanezumab) has produced positive results in its phase 3 study in patients who have failed previous preventative treatments.
Reply Retweet Like
Quanticate Sep 20
[FREE WHITEPAPER] Quanticate’s Principal Statisticians outlines the issues that can arise in the planning of an Integrated Summary of Safety (ISS) and Integrated Summary of Effectiveness (ISE)
Reply Retweet Like
bluebird bio Sep 3
News from the Nest: our flock will be presenting updated data from our phase 2/3 of our investigational treatment for Cerebral Adrenoleukodystrophy at later this month
Reply Retweet Like
OCRC Sep 20
If you want to put your science degree to use, make a difference in people’s lives, and contribute to medical breakthroughs, there’s a good chance that a career in might be a great fit for you!Learn more:
Reply Retweet Like
QUARTESIAN Jul 9
ICYMI: Our agreement with gives us complete access to the unified Medidata Clinical Cloud® and their platform. Discover how we leverage these assets for your :
Reply Retweet Like
Vedanta Biosciences Jul 1
Pleased to announce the first patient has been enrolled in the Phase 1b/2 of our live biotherapeutic product candidate, VE416, being developed for the treatment of food allergies
Reply Retweet Like
Diego Menchaca Sep 12
Whether you are conducting a in a remote village in Somalia or in a hospital in the Netherlands, you are not assured to have a stable internet connection. Learn what considerations you must keep in mind when collecting data :
Reply Retweet Like
Harvard Catalyst Sep 5
Junior investigators: Did you know? Harvard Catalyst offers free biostatistical consultations & guidance on your design from , , , & :
Reply Retweet Like
Ovid Therapeutics Sep 12
We are proud to announce that the first has been randomized in our Phase 3 evaluating OV101 for . To learn more, visit
Reply Retweet Like
The CIPHER Study Jan 21
We have now recruited over 400 patients into the CIPHER study! Recruitment dipped in December but hopefully we can get the pace back up. Well done to all the recruiting sites!
Reply Retweet Like
Sarah Manning Dec 14
AIM course done & dusted.passed with 💯 boom! next stop AACD..the studying doesn’t stop once you qualify kids!
Reply Retweet Like
NewDartagnan May 17
AMO Pharma : Results of Phase 2 Study of AMO-02 in Adolescents with Autism Spectrum Disorder
Reply Retweet Like
Easy Medical Device Sep 9
How to do a product equivalence for your Clinical Evaluation Report CER? By and
Reply Retweet Like
Marizyme, Inc. Feb 25
American Heart Association: Study shows need for Thrombectomy-capable Stroke Centers remains high in 64 percent of communities studied
Reply Retweet Like
Merryman Comm Mar 11
We're helping Regentis Biomaterials recruit patients for a for a new treatment for cartilage damage in the knee. One of the first patients treated with GelrinC just celebrated one year since her surgery and is back to skiing!
Reply Retweet Like
PureTech Jul 1
Our affiliate announced the first patient enrolled in the Phase 1b/2 of its live biotherapeutic product candidate, VE416, marking the first clinical study of a rationally-defined bacterial consortium to treat
Reply Retweet Like
OCRC Sep 13
Without , medical innovation simply would not exist! Researchers are currently looking for study participants. See if you qualify at:
Reply Retweet Like